Stock AMRX AMNEAL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Amneal Pharmaceuticals, Inc.

Equities

AMRX

US03168L1052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
6.87 USD +0.29% Intraday chart for Amneal Pharmaceuticals, Inc. +4.25% +13.18%
May. 06 Goldman Sachs Adjusts Amneal Pharmaceuticals Price Target to $8 From $6.25, Maintains Buy Rating MT
May. 03 Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating MT

Chart calendar Amneal Pharmaceuticals, Inc.

d2b0330ea548183f7d775e555f.ORlq4A_WD85C6uTmwhdzmTS9ABE78HY62cw5QRant3g.UmwLg0T7QIw22Lynm1UH1wzadHt8xRxD9P94JjvGjjpYSQuaZbI-lHDc3A~ae833db232e187615953c702be6e756e

Upcoming events on Amneal Pharmaceuticals, Inc.

2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)
2025-05-01 Q1 2025 Earnings Release (Projected)

Past events on Amneal Pharmaceuticals, Inc.

2024-05-03 08:30 am Q1 2024 Earnings Call
2024-05-03 06:00 am Q1 2024 Earnings Release
2024-05-02 09:00 am Annual General Meeting
2024-03-13 08:30 am Barclays Global Healthcare Conference
2024-03-01 08:30 am Q4 2023 Earnings Call
2024-03-01 06:00 am Q4 2023 Earnings Release
2024-01-10 02:15 pm JPMorgan Healthcare Conference
2023-08-04 08:30 am Q2 2023 Earnings Call
2023-08-04 06:00 am Q2 2023 Earnings Release
2023-06-07 02:30 pm Jefferies Global Healthcare Conference
2023-05-09 09:00 am Annual General Meeting
2023-05-05 08:30 am Q1 2023 Earnings Call
2023-05-05 06:00 am Q1 2023 Earnings Release
2023-04-19 11:45 am Needham Healthcare Conference - Fireside Chat
2023-03-02 08:30 am Q4 2022 Earnings Call
2023-03-02 05:00 am Q4 2022 Earnings Release
2023-01-10 05:15 pm JP Morgan Healthcare Conference
2022-11-30 Piper Sandler Healthcare Conference
2022-11-04 08:30 am Q3 2022 Earnings Call
2022-11-04 06:00 am Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		1 626
1 610
1.03%		1 993
1 990
0.14%		2 094
2 092
0.06%		2 212
2 183
1.36%		2 394
2 411
-0.74%
2 666

EBITDA
Million USD		Released
Forecast
Spread 		356
351
1.34%		456
453
0.63%		538
541
-0.58%		514
501
2.67%		558
550
1.55%
611

EBIT
Million USD		Released
Forecast
Spread 		292
283
3.4%		326
381
-14.49%		388
467
-16.87%		343
408
-15.85%		379
483
-21.55%
552

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-220
0,00
- 		-35,8
227
-115.76%		0,00
0,00
- 		0,00
0,00
- 		-40,7
46,6
-187.42%
-58,3

Net income
Million USD		Released
Forecast
Spread 		-604
-345
-74.85%		68,6
6,15
1015.09%		20,2
59,7
-66.21%		0,00
0,00
- 		-84,0
23,0
-465.82%
-84,2

EPS
USD		Released
Forecast
Spread 		-2,74
-3,65
24.93%		0,61
0,04
1425%		0,07
0,05
40%		-0,86
-0,74
-17.01%		-0,48
0,05
-1060%
-0,27

Announcement Date26/02/2026/02/2101/03/2202/03/2301/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		498
502
-0.93%		559
534
4.66%		546
562
-2.96%		610
580
5.14%		558
542
2.83%		599
565
6%		620
605
2.57%		617
635
-2.82%		659
619
6.49%
664


666


676


682


690

EBITDA
Million USD		Released
Forecast
Spread 		99,9
104
-3.59%		135
129
4.35%		126
132
-4.79%		154
145
6.05%		116
103
13.35%		146
122
19.6%		154
152
0.98%		142
130
9.34%		152
130
16.75%
144


148


151


151


151

EBIT
Million USD		Released
Forecast
Spread 		81,3
83,7
-2.91%		119
111
7.93%		107
110
-3.1%		105
121
-13.12%		129
86,2
49.41%		124
100,0
24.37%		132
122
8.59%		93,0
126
-26.1%		169
109
55.85%
137


140


140


130


141

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread

















23,0
22,8
0.64%		-83,5
3,39
-2563.43%		-75,5
-2,58
-2822.68%
4,35


5,56


7,33


15,1


15,6

Net income
Million USD		Released
Forecast
Spread 		-2,16
7,30
-129.53%		-121
20,2
-698.06%











9,68
17,9
-45.93%		-98,6
1,06
-9371.52%		-91,6
-0,81
-11270.1%
1,88


2,40


3,17


4,73


4,89

EPS
USD		Released
Forecast
Spread 		-0,01
0,00
- 		-0,80
-0,61
-31.15%		-0,02
0,04
-150%		-0,03
0,07
-142.86%		-0,05
-0,03
-66.67%		0,08
-0,01
900%		0,06
0,06
0%		-0,40
0,00
- 		-0,30
0,00
-
0,01


0,01


0,01


0,01


0,02

Announcement Date04/05/2205/08/2204/11/2202/03/2305/05/2304/08/2307/11/2301/03/2403/05/24-----

Upcoming sector events for Amneal Pharmaceuticals, Inc.

2024-05-16 J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-16 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-20 TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release (Projected)
2024-05-21 CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release (Projected)
2024-05-21 GLAND PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-22 ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-23 TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-26 NATCO PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-26 DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-27 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Amneal Pharmaceuticals, Inc.

Today MANKIND PHARMA LIMITED: Q4 2024 Earnings Release
Today CRESCO LABS INC.: Q1 2024 Earnings Release
Today GRANULES INDIA LIMITED: Q4 2024 Earnings Release
Today EISAI CO., LTD.: Q4 2023 Earnings Release
Today DERMAPHARM HOLDING SE: Q1 2024 Earnings Release
2024-05-14 05:43 pm LIQUIDIA CORPORATION: Q1 2024 Earnings Release
2024-05-14 04:52 am BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release
2024-05-14 01:30 am BAYER AG: Q1 2024 Earnings Release
2024-05-13 SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-13 PRESTIGE CONSUMER HEALTHCARE INC.: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AMRX Stock
  4. Calendar Amneal Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW